- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-HECTD3
HECTD3 Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IP, IF, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 11487-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules MCF-7, cellules MDA-MB-453s |
Résultats positifs en IP | cellules MDA-MB-453s |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:3000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 2 publications below |
WB | See 4 publications below |
IF | See 1 publications below |
IP | See 1 publications below |
CoIP | See 1 publications below |
Informations sur le produit
11487-1-AP cible HECTD3 dans les applications de WB, IP, IF, CoIP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | HECTD3 Protéine recombinante Ag1998 |
Nom complet | HECT domain containing 3 |
Masse moléculaire calculée | 861 aa, 97 kDa |
Poids moléculaire observé | 97 kDa |
Numéro d’acquisition GenBank | BC019105 |
Symbole du gène | HECTD3 |
Identification du gène (NCBI) | 79654 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
HECTD3(HECT domain-containing protein 3) may be involved in the regulation of mitotic metaphase/anaphase transition. It can specifically ubiquitinate TRIOBP and target it for proteasomal degradation and it can also mediates the ubiquitination of STX8. HECTD3 is a new oncogenic E3 ligase in human prostate cancer.( Li Y, etc. 2008) HECTD3 may facilitate cell cycle progression via regulating ubiquitination and degradation of Tara(PMID:18194665). It has 2 isoforms produced by alternative splicing.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for HECTD3 antibody 11487-1-AP | Download protocol |
IP protocol for HECTD3 antibody 11487-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Commun E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3. | ||
Front Oncol uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation. | ||
Cell Death Discov HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC.
| ||
Br J Cancer HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway
| ||
Cell Death Dis Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells | ||
Cell Death Dis HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Wei (Verified Customer) (01-23-2020) | Good, single band
|